Where is your prescribed psoriasis treatment made?

[Fred]

I don't want this to turn into a political thread and that is not it's intention. But the political situation around the world has got me thinking about our treatments and how things could possibly change in the future.

#1 There has been a lot of talk lately about of possible future trade problems/negotiations after the Trump win in the USA and Brexit in the UK, so how will that effect our treatments?

#2 Also do the drug companies make their treatments in different parts of the world depending on where they sell them and could that change?

I'm currently on Cosentyx which is made by Novartis. They are a Swiss company but my box of Cosentyx has Crawley UK on the back. I live in France and the packaging and leaflet is in French. I'm guessing that my treatment is made in the UK because of the packaging, if it was made in France or Switzerland surely it would have that on the back of the box. So will my Cosentyx still be made in the UK after Brexit and will the price change?

I would be interested to know what others think, and where your prescribed psoriasis treatment is made.

[jiml]

I'm on Fumaderm manufactured and marketed by Biogen, and the fact that the packaging is all in German leads me to believe that it is made in Germany



I don't think the fact that Trump is in power, or brexit will happen will have much effect . We all need trading partners, the US, Europe and United Kingdom. Life will go on and deals will have to be done, leaving something because you want self rule, doesn't have to involve ceasing to trade.... that will be harmful to all countries.
So I'm guessing when all the posturing is done, that the world will go on trading . But that's just my opinion looking through rose tinted glasses

[Fred]

Thank you Jim. Yes I'm sure trading will still go on around the world, but I'm wondering if someone like Novartis will have to make some changes and it could effect delivery and/or cost.

The may get a good deal that means they can keep making Cosentyx in the UK, but will they get a good deal to export to France or will they have to still get a deal through the EU before they can export to France?

Trump has made it clear he wants the people of the USA to buy USA manufactured goods or pay high tax's for imports. I wonder if Cosentyx is also made in the USA.

Certainly interesting times ahead and hopefully none of us will lose our treatments.

[Caroline]

I share your concerns, but like Jim I think new deals will be made. Will they be better or worse that is the question.
For the DMF it will even be broader available. USA has their Tecf*dera, but that is too costly to use for Psoriasis.
But from Spains Almirall a new one will come, and probably in the price range of Fumaderm. They might also export too. Europe or even to the USA. The last would be interesting.
For the Netherlands Psorinovo is produced in the Netherlands itself, so unless some stupid regulation ends that, some Pharma would like that, it will stay being produced.

[Fred]

I share your concerns, but like Jim I think new deals will be made. Will they be better or worse that is the question.
For the DMF it will even be broader available. USA has their Tecf*dera, but that is too costly to use for Psoriasis.
But from Spains Almirall a new one will come, and probably in the price range of Fumaderm. They might also export too. Europe or even to the USA. The last would be interesting.
For the Netherlands Psorinovo is produced in the Netherlands itself, so unless some stupid regulation ends that, some Pharma would like that, it will stay being produced.

I'm not so much concerned more curious as like you say deals will be done and for me personally as Novartis is a Swiss company I don't see a problem continuing to get Cosentyx in France as both countries already have a good relationship. The problem that could arise would be if indeed my Cosentyx is made in the UK as I think it is I can see some problems for Novartis (who are after all said and done only in it for the money)

As for Almirral wouldn't they have to abide by the EU rules of trade of LAS41008 to the UK and USA and to possible new tariffs on imports in those countries?

I'm sure the governments and companies will find a way around these problems as they need each other, but it could cause some disruption for new treatments or even possible withdrawal of some psoriasis treatments in different countries.

[D Foster]

Ministers are coming under growing pressure to scrap plans to quit Europe’s medicines regulator as part of Brexit, with drug firms saying doing so could force Britons to wait a year longer than patients in the EU to access new drugs.

Labour and leaders of the UK’s pharmaceutical industry fear that patients and the NHS will lose out if Britain gives up its membership of the European Medicines Agency (EMA). The health secretary, Jeremy Hunt, told MPs last week that he did not expect the UK to continue as a member once it left the EU.

Several EU states, including the Netherlands and the Republic of Ireland, have already expressed interest in hosting the EMA’s headquarters if and when it relocates from London with its 890 medical, scientific and managerial staff. Hunt said it was likely the EMA would move as a result of Brexit.
The shadow health secretary, Jonathan Ashworth, has written to Hunt branding departure from the EMA “reckless and unbelievable” and highlighting the “damaging loss of jobs and wealth from our shores” it would involve.

He said that British people would face “longer waiting periods to access life-saving treatments”. He added: “If we leave the EMA we could, like Canada and Australia, have to wait for many months before being able to buy drugs already available in bigger markets like the EU and the United States.”

The Association of the British Pharmaceutical Industry (ABPI), which represents drug firms employing about 220,000 people in the UK, voiced similar concerns. Dr Virginia Acha, its executive director for research, medical and innovation, said that Britain being outside the EMA could lead to patients waiting six to 12 months longer than the rest of Europe to receive newly developed medicines because the UK would be a small market rather than part of a large EU-wide one.

“While there is opportunity in creating a bespoke regulatory framework for the UK, if this operates outside of the EMA, the added time, cost and burden of having to seek additional regulatory approval in a separate system is likely to mean British patients’ access to medicines will face even greater delay,” Acha said.

[mataribot]

It's irrelevant in the long run. If there's money to be made, the treatment will be available. The people complaining otherwise sound like children in the back seat of car - "are we there yet?"

[Fred]

It's irrelevant in the long run. If there's money to be made, the treatment will be available. The people complaining otherwise sound like children in the back seat of car - "are we there yet?"

But you can't go against a countries wishes. It doesn't matter how much money they put in or how many customers there are, the country has to give you permission to sell. They also have to make the rules attractive enough for the company to want to sell in a country.

So future trade deals and tariffs are relevant.

[mataribot]

As long as there is a potential for money to be earned and product is safe there isn't much concern about the product coming to market, at least not in westernized countries.

One side of the spectrum isn't going to make as much money as they use to, so now they are crying like a baby that the worlds ending.

I wouldn't worry about too much. Just my 2 cents

[Fred]

As long as there is a potential for money to be earned and product is safe there isn't much concern about the product coming to market, at least not in westernized countries.

One side of the spectrum isn't going to make as much money as they use to, so now they are crying like a baby that the worlds ending.

I wouldn't worry about too much. Just my 2 cents

I'll leave it there.